EICCX
Price
$17.43
Change
+$0.03 (+0.17%)
Updated
Jun 5 closing price
Net Assets
329.36M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

EICCX vs RMEBX

Header iconEICCX vs RMEBX Comparison
Open Charts EICCX vs RMEBXBanner chart's image
EIC Value C
Price$17.43
Change+$0.03 (+0.17%)
VolumeN/A
Net Assets329.36M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
EICCX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EICCX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EICCX is a StrongBuy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. EICCX (329M). EICCX pays higher dividends than RMEBX: EICCX (1.27) vs RMEBX (1.16). EICCX was incepted earlier than RMEBX: EICCX (14 years) vs RMEBX (11 years). EICCX (2.00) is less costly to investors than RMEBX (1.07). EICCX is a more actively managed with annual turnover of: 38.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than EICCX: RMEBX (250) vs EICCX (2500). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. EICCX (5.10). RMEBX return over 5 years is better than : 49.85 vs. EICCX (42.51).
EICCXRMEBXEICCX / RMEBX
Total Expense Ratio1.961.07183%
Annual Report Gross Expense Ratio2.001.07187%
Fund Existence14 years11 years-
Gain YTD6.8145.349127%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets329M105B0%
Annual Yield % from dividends1.271.16110%
Returns for 1 year5.108.3061%
Returns for 3 years11.6217.9665%
Returns for 5 years42.5149.8585%
Returns for 10 years39.2468.2158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA